P2Y2R activation by nucleotides released from oxLDL-treated endothelial cells (ECs) mediates the interaction between ECs and immune cells through RAGE expression and reactive oxygen species production
Authors:
- 1 April 2014
- journal article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 69, 157-166
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Science, and Technology (2012R1A1A3003268)
This publication has 45 references indexed in Scilit:
- Anti-inflammatory therapeutics for the treatment of atherosclerosisNature Reviews Drug Discovery, 2011
- Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivityJournal of Experimental Medicine, 2010
- Interleukin‐1β enhances nucleotide‐induced and α‐secretase‐dependent amyloid precursor protein processing in rat primary cortical neurons via up‐regulation of the P2Y2 receptorJournal of Neurochemistry, 2009
- Regulation of macrophage function in inflammation and atherosclerosisJournal of Lipid Research, 2009
- The P2Y2 Nucleotide Receptor Interacts with αv Integrins to Activate Go and Induce Cell MigrationJournal of Biological Chemistry, 2005
- Inflammation in atherosclerosisNature, 2002
- Functional P2Y 2 Nucleotide Receptors Mediate Uridine 5′-Triphosphate–Induced Intimal Hyperplasia in Collared Rabbit Carotid ArteriesCirculation, 2002
- Expression of adhesion molecules by human endothelial cells exposed to oxidized low density lipoprotein Influences of degree of oxidation and location of oxidized LDLAtherosclerosis, 2001
- The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell deathImmunology Today, 1995
- Glycation and oxidation: A role in the pathogenesis of atherosclerosisThe American Journal of Cardiology, 1993